Medtronic Plc. · NYSE:MDT

Medtronic — Investor Presentation (2017)

29 slides from Medtronic's investor presentation, 2017

  1. Slide 1: TruRhythm Detection inside the Reveal LINQ Insertable Cardiac Monitoring System

    NEW INTELLIGEN INSIDE. CE TruRhythm™ Detection inside the Reveal LINQ™ Insertable Cardiac Monitoring System World’s Smallest ICM. Now Smarter.

  2. Slide 2: Reveal ICM Evolution

    REVEAL™ ICM EVOLUTION  Accuracy  Work Flow

  3. Slide 3: Evolution of Reveal ICMs

    TRURHYTHM™ DETECTION INSIDE EVOLUTION OF REVEAL™ ICMs Now smarter TruRhythm™ Detection World’s smallest ICM NEW intelligence inside the Reveal LINQ ICM ™ Reveal LINQ™ ICM World’s first ILR Reveal™ ILR 1998 2014 2017 TruRhythm™ Detection Inside the Reveal LINQ™ 3 ICM

  4. Slide 4: Accuracy Evolution

    TRURHYTHM™ DETECTION INSIDE ACCURACY EVOLUTION TruRhythm ™ Detection Reveal LINQ™ Reveal™ XT With FullView ™ Software Reveal™ XT Streamlined episode review for clinic efficiency1,2 NEW Pause NEW simplified insertion NEW algorithms with PAUSE algorithm and tight pocket for better  Smart filtering wi

  5. Slide 5: Work Flow Evolution

    TRURHYTHM™ DETECTION INSIDE WORK FLOW EVOLUTION TruRhythm ™ Detection NEW services and education CareLink™ advancements Reveal LINQ™ ICM Best-in-class data  Reveal LINQ ™ to streamline All patient and clinical data are fictitious and for demonstration Mobile Manager episode review1,2 purposes only.

  6. Slide 6: The Journey

    TRURHYTHM™ DETECTION INSIDE THE JOURNEY Clinical need 50,000+ ECGs TruRhythm Detection TM Clinicians said Over 50,000 real- NEW exclusive and intelligent streamlined data world ECGs algorithms that streamline episode was biggest need analyzed to increase review1 device accuracy 1 TruRhythm™ Detectio

  7. Slide 7: Intelligent, Actionable Detection

    TRURHYTHM™ DETECTION INSIDE INTELLIGENT ACTIONABLE NEW WORK FLOW ALGORITHMS EFFICIENCY  Smart filtering  false detects 54%*1  Self-learning  Streamlined episode review and reporting1,2 1 TruRhythm™ Detection Algorithms. Medtronic data on file. 2017. 2 TruRhythm™ Detection Efficiency. Medtronic d

  8. Slide 8: New Algorithms

    NEW ALGORITHM S  Smart filtering  Self-learning intelligence

  9. Slide 9: Smart Filtering and Self-Learning Intelligent Detection

    TRURHYTHM™ INTELLIGENT DETECTION NEW ALGORITHMS SMART SELF-LEARNING FILTERING NEW second sensing filter Exclusive fifth-generation analyzes rhythms for atrial fibrillation possible undersensing in algorithm learns and Brady and Pause adapts to patient’s rhythm over time BRADY PAUSE & AF TruRhythm™ D

  10. Slide 10: Brady and Pause Episodes

    TRURHYTHM™ INTELLIGENT DETECTION CLINICAL NEED BRADY AND PAUSE EPISODES BRADY  Reduce false detects from undersensing of PVCs1 &  Reduce false detects from undersensing of small R- PAUSE waves1 PVCs example Small R-waves example Above image: Detection threshold of first sensing filter Above image:

  11. Slide 11: Smart Filtering Algorithm

    TRURHYTHM™ INTELLIGENT DETECTION BRADY AND PAUSE SOLUTION SMART FILTERING ALGORITHM BRADY Exclusive second filter rejects Brady and Pause episodes & with: PAUSE EVIDENCE OF PVCs EVIDENCE OF SMALL R- PVCs example WAVES Small R-waves example Above image: Threshold of new, second filter detects PVCsAbo

  12. Slide 12: Intelligent Detection: AF Episodes

    TRURHYTHM™ INTELLIGENT DETECTION CLINICAL NEED AF EPISODES Further enhance current AF algorithm to improve AF discrimination AF in patients with irregular sinus arrhythmias (sick sinus or PACs) CHALLENGE TODAY Algorithm cannot adapt based on a AF detection The Reveal LINQ™ ICM’s patient’s history al

  13. Slide 13: Self-Learning Algorithm

    TRURHYTHM™ INTELLIGENT DETECTION AF SOLUTION SELF-LEARNING ALGORITHM Exclusive fifth-generation AF algorithm learns and adapts AF to a patient’s daily rhythm 1. LEARNS 2. ADAPTS 3. REJECTS AF algorithm tracks R- Self-learning Self-learning wave variability in a algorithm collects P- algorithm reject

  14. Slide 14: Work Flow Efficiency

    WORK FLOW EFFICIENCY  Episode reduction  Report improvements

  15. Slide 15: Streamlined Episode Review

    TRURHYTHM™ ACTIONABLE DETECTION STREAMLINED EPISODE REVIEW1 54% reduction in false detects*1 Significant reduction in episode review1 1 TruRhythm™ Detection Algorithms. Medtronic data on file. 2017. *Compared with the Reveal LINQ™ ICM without TruRhythm™ Detection TruRhythm™ Detection Inside the Reve

  16. Slide 16: Fewer False Detects; Maintained Sensitivity

    TRURHYTHM™ ACTIONABLE DETECTION FEWER FALSE DETECTS; MAINTAINED SENSITIVITY1 BEST-IN-CLASS DATA  Reduce episode review burden with fewer false detects1  Maintain clinical success without sacrificing sensitivity 1 REDUCTION IN RELATIVE FALSE DETECTS*1 SENSITIVITY1 BRADY 95% 98.3%† PAUSE 47% 99.4%†

  17. Slide 17: More Actionable AF Reports

    TRURHYTHM™ ACTIONABLE DETECTION REPORTING IMPROVEMENTS MORE ACTIONABLE AF REPORTS  30 seconds of ECG for longest AF episodes  2 minutes of markers of longest AF episode AF episodes will show 30 seconds of ECG AF episodes will have ~2 minutes of vs. intervals vs. 10 seconds, from wireless transmiss

  18. Slide 18: More Efficient Review

    TRURHYTHM™ ACTIONABLE DETECTION TIME SAVINGS MORE EFFICIENT REVIEW  Save clinician time with review of fewer false detects 1,2 Estimated time reviewing false detects* Total Device Patients Monitored Data Transmitted to 56 % less clinician time Device Clinic spent reviewing data*2 True False Cardiac

  19. Slide 19: Average Event Review Time

    TRURHYTHM™ ACTIONABLE DETECTION TIME SAVINGS CALCULATION AVERAGE EVENT REVIEW TIME Manual Clinician Physician TOTAL Transmission + Review + Review = TIME (if needed) TruRhythm™ Detection improves report accuracy, resulting in a reduction of total Clinic review time calculated clinician time spent re

  20. Slide 20: Proven Solution

    PROVEN SOLUTION  Clinical rigor  Confidence across indications

  21. Slide 21: Reveal ICM: Most Studied and Published

    REVEAL™ ICM: MOST STUDIED AND PUBLISHED 50M Most clinically days of real- world patient validated ICM in cryptogenic stroke, syncope, follow-up — the and atrial most of any fibrillation patients2- ICM manufacturer1 4 50+ published 500+ published detection clinical articles performance and abstracts6

  22. Slide 22: Proven Detection Confidence Across Indications

    TRURHYTHM™ PROVEN DETECTION CONFIDENCE ACROSS INDICATIONS Cryptogenic Syncope Atrial stroke fibrillation Why Reveal LINQ™ Why Reveal LINQ™ ICM? Why Reveal LINQ ™ ICM? 78% of patients with ICM? 88% percent of AF recurrent syncope are Short and intermittent patients would be missed diagnosed with an I

  23. Slide 23: New Intelligence to Guide Decisions

    TRURHYTHM™ DETECTION NEW INTELLIGENCE TO GUIDE DECISIONS INTELLIGENT ACTIONABLE PROVEN Exclusive NEW Best-in-class data Most studied with smart filtering to streamline 500+ clinical and self-learning episode review1 articles and algorithms1 abstracts2 1 TruRhythm™ Detection Algorithms. Medtronic dat

  24. Slide 24: Thank You

    THANK YOU

  25. Slide 25: References

    REFERENCES In order of appearance on slides 1 TruRhythm™ Detection Algorithms. Medtronic data on file. 2017. 2 TruRhythm™ Detection Efficiency. Medtronic data on file. 2017. 3 Reveal LINQ ICM Days of Follow-Up. Medtronic data on file. 2017. 4 Sanders P, Pürerfellner H, Pokushalov E, et al. Performan

  26. Slide 26: Indications, Safety, and Warnings

    Indications, Safety, and Warnings If you are located in the United States, please refer to the brief statement(s) below to review applicable indications, safety and warning information. See the device manual for detailed information regarding the implant procedure, indications, contraindications, wa

  27. Slide 27: Brief Statement

    Brief Statement Medtronic MyCareLinkTM Patient Monitor, CareLinkTM Network, CareLink Mobile Application, Reveal LINQ TM Insertable Cardiac Monitor, Patient Assistanct, and Reveal LINQ Mobile Manager The Medtronic MyCareLink patient monitor and the Medtronic CareLink network are indicated for use in

  28. Slide 28: Brief Statement (cont'd)

    Brief Statement (cont’d) Medtronic MyCareLinkTM Patient Monitor, CareLinkTM Network, CareLink Mobile Application, Reveal LINQ TM Insertable Cardiac Monitor, Patient Assistanct, and Reveal LINQ Mobile Manager Reveal LINQ Mobile Manager System Radiofrequency (RF) interference — Portable and mobile Bef

  29. Slide 29: Brief Statement (cont'd)

    Brief Statement (cont’d) Medtronic MyCareLinkTM Patient Monitor, CareLinkTM Network, CareLink Mobile Application, Reveal LINQ TM Insertable Cardiac Monitor, Patient Assistanct, and Reveal LINQ Mobile Manager Potential Complications: Potential complications of the CareLink network availability and mo

Medtronic — Investor Presentation (2017) on 6ix